Temporary Exclusion of Mogadon Tablet
- Mogadon tablet, previously regulated as a dangerous drug, is temporarily excluded from this category.
- This exclusion follows prior Board Regulations Nos. 2 and 5, series of 1977.
- The decision to extend this exclusion was made during the DDB meeting on February 15, 1978.
- The extension period is for one (1) year, beginning January 20, 1978.
Conditions for Dispensing Mogadon Tablet
- Dispensing of Mogadon tablet requires an ordinary prescription as mandated under R.A. 3720, known as the Food, Drug and Cosmetic Act.
- Prescriptions must include:
- Name and address of the prescribing physician.
- Number of Privilege Tax Receipt and Opium License of the physician.
- Name and address of the patient.
Automatic Reversion after Expiration
- After the extension period elapses, Mogadon will automatically revert to being categorized as a regulated drug.
- Any further exclusion beyond the one-year period requires a new extension from the Dangerous Drugs Board.
Early Termination Clause
- The one-year extension may be terminated earlier if evidence shows that Mogadon tablet is being abused.
- This clause allows for swift action to control substance misuse.
Effective Date and Authority
- This regulation took effect on January 20, 1978.
- Signed and adopted by Clemente S. Gatmaitan, M.D., M.P.H., Chairman of the Dangerous Drugs Board, on February 28, 1978.